JONES FINANCIAL COMPANIES LLLP

Position in BHC — Bausch Health Companies Inc.

CIK 815917 DES PERES, MO

Back to BHC Full portfolio

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$764

-$73 QoQ

Shares Held

155

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#203

of 220 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $116,301,284 across 50 Drug Manufacturers - Specialty & Generic names. BHC ranks #45 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	7,116,095	$66,393,166
2	ZTS	Zoetis Inc.	191,729	$13,777,645
3	TEVA	Teva Pharmaceutical Industries Ltd	332,250	$11,256,629
4	PBH	Prestige Consumer Healthcare Inc.	179,743	$8,496,451
5	NBIX	Neurocrine Biosciences Inc	33,495	$5,645,247
6	UTHR	UNITED THERAPEUTICS Corp	4,777	$2,588,321
7	VTRS	Viatris Inc	136,476	$2,167,238
8	AMRX	Amneal Pharmaceuticals, Inc.	110,479	$1,912,391

All Filings in BHC

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$764	155	0.0%	Shares	Sole	2026-08-14
2026-03-31	$837	155	+244.4%	Shares	Sole	2026-05-15
2025-12-31	$312	45	-92.0%	Shares	Sole	2026-02-17
2025-09-30	$3,631	563	-42.6%	Shares	Sole	2025-11-04
2025-06-30	$6,526	980	+37.3%	Shares	Sole	2025-08-13
2025-03-31	$4,619	714	-52.8%	Shares	Sole	2025-05-28
2024-12-31	$12,202	1,514	+89.2%	Shares	Sole	2025-02-06
2024-09-30	$6,528	800	+68.1%	Shares	Sole	2024-11-12
2024-06-30	$3,317	476	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.